23,997 results match your criteria British Journal Of Dermatology[Journal]


Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

Dermatology and Venereology Private Practice, Bari and Barletta, Italy.

Background: The infection caused by the recently identified SARS-CoV-2, called COronaVIrus Disease-19 (COVID-19), has rapidly spread throughout the world. With the exponential increase of patients worldwide, the clinical spectrum of COVID-19 is being better defined and new symptoms are emerging. Numerous reports are documenting the occurrence of different cutaneous manifestations in COVID-19 patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19264DOI Listing

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study).

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

University Hospitals Birmingham, Birmingham, UK.

Background: The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study is a prospective analysis of an international database and here we examine front-line treatments and quality-of-life in patients with newly diagnosed Mycosis Fungoides (MF).

Objectives: a) differences in first-line approach according to the TNMB staging; b) parameters related to a first-line systemic approach; c) response rates and quality of life (QoL) measures.

Patients And Methods: 395 newly diagnosed patients with early-stage MF (IA-IIA) were recruited from 41 centers in 17 countries between 1/1/2015-31/12/2018 following central clinicopathological review. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19252DOI Listing

Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy.

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Lombardy, Bergamo, Italy.

Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are blistering disorders associated with barrier disruption, immune dysregulation and use of immunosuppressing systemic therapy. Patients with BP and PV have higher potential risk factors for infections secondary to skin alterations, comorbidity and chronic treatment with immunosuppressing agents. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19266DOI Listing

First- and third- generation EGFR inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatologic reactions.

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

Department of Anesthesiology, Duke University School of Medicine, Durham, NC, 27701, USA.

Epidermal growth factor receptor (EGFR) inhibitors are used to treat several malignancies but notoriously exert dermatologic toxicities, reducing patient adherence. Despite targeting the same receptor, different EGFR inhibitors exhibit distinct toxicities. Up to 90% of patients on EGFR inhibitors present with a papulopustular rash, with varying severity and frequency depending on the inhibitor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19263DOI Listing

Targeting fear of recurrence: The advantages of assessing psychosocial attributes and psychological dispositions.

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

Rita Levi Montalcini, Department of Neuroscience, Psycho-Oncology Unit, University of Turin, Metropolitan City, Italy.

We found the randomized controlled trial of a brief psychological intervention targeting fear of recurrence of melanoma patients by Dieng et al. very interesting. The intervention has been shown to be effective and its implementation in the routine care of melanoma patients seems appropriate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19261DOI Listing

The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations.

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

Department of Dermatology, Reference Centre for Genodermatoses and rare skin diseases (MAGEC), Imagine Institute, Necker-Enfants Malades Hospital (AP-HP), Paris, France.

Background: Netherton syndrome (NS) is a rare disease caused by SPINK5 mutations, featuring variable skin and hair involvement and, in many cases, allergic manifestations with a risk of lethality particularly in infants. The clinical management is challenging.

Objectives: To analyse the clinical manifestations of a cohort of NS infants managed in a reference centre. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19265DOI Listing

Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

Novartis Pharma AG, Basel, Switzerland.

Background: Secukinumab, a fully human monoclonal antibody that selectively neutralises interleukin-17A, a cornerstone cytokine in psoriasis, has shown long-lasting efficacy and safety in the complete spectrum of psoriasis manifestations.

Objective: To report the long-term (2.5-year) efficacy and safety of secukinumab in nail psoriasis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19262DOI Listing

miRNA analysis of Childhood Atopic Dermatitis reveals a role for miR-451a.

Br J Dermatol 2020 Jun 1. Epub 2020 Jun 1.

National Children's Research Centre, Crumlin, Dublin, Ireland.

Background: MicroRNAs (miRNAs), important regulators of gene expression, have been implicated in a variety of disorders. The expression pattern of miRNAs in pediatric atopic dermatitis (AD) has not been well studied.

Objective: We sought to investigate miRNA expression profiles in different blood compartments of infants with AD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19254DOI Listing

Publication of national dermatology guidelines as a Research Letter in the BJD: can less ever be enough?

Br J Dermatol 2020 Jun;182(6):1319-1320

Division of Infection and Immunity, Cardiff University, Cardiff, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.18952DOI Listing

Notice of withdrawal.

Authors:

Br J Dermatol 2020 Jun 19;182(6):1510. Epub 2020 Mar 19.

L. Frommherz, J. Küsel, A. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19019DOI Listing

Corrigendum.

Authors:

Br J Dermatol 2020 Jun;182(6):1509

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.18386DOI Listing

Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.

Br J Dermatol 2020 Jun;182(6):e186-e209

Atopic dermatitis (also known as AD or eczema) is a common skin disease that can cause intense and persistent itching and rashes. Skin creams or ointments are not suitable or effective for some patients with moderate-to-severe AD. In these patients, oral (taken by mouth) or injected medications may be required. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19065DOI Listing

First real-world data provide evidence for a 'window of opportunity' in treatment of hidradenitis suppurativa/acne inversa.

Authors:
C C Zouboulis

Br J Dermatol 2020 May 31. Epub 2020 May 31.

Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Auenweg 38, 06847, Dessau, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19165DOI Listing

Risk of keratinocyte carcinoma among patients with hidradenitis suppurativa.

Br J Dermatol 2020 May 30. Epub 2020 May 30.

Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.

Hidradenitis suppurativa (HS), also known as acne inversa, is a chronic inflammatory disorder of the pilosebaceous units. To date, studies on the risk of keratinocyte carcinoma (KC), defined as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), among HS patients have been limited. We performed a case-control study comparing the incidence of BCC and SCC in HS patients (cases) to that in acne vulgaris patients (controls), which is also an inflammatory disorder of the pilosebaceous unit. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19256DOI Listing

Assessment of patient knowledge and completion of advance directives in oncodermatology.

Br J Dermatol 2020 May 30. Epub 2020 May 30.

Dermatology Department, CHRU of Nancy, Nancy, France.

Advance directives (AD) are the possibility for any individual to express their wishes on how to be cared at the end of life, when they can no longer make the decisions themselves. In France, AD are only applicable during the end-of-life period, such as after an irrecoverable accident or at a terminal phase of a disease. It appeared for the first time in France in 2005 with the Léonetti law, which discussed matters related to the end of life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19257DOI Listing

Virtual melanoma checks during a pandemic.

Br J Dermatol 2020 May 29. Epub 2020 May 29.

The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.

Healthcare services internationally are experiencing unprecedented strain due to the COVID-19 pandemic. Governments mandate strict social distancing to reduce the spread of SARS-CoV-2 infection, and as a result, people are avoiding health services for less urgent issues. In this crisis, it is important that patients continue to receive preventive and surveillance care without compromising their safety or that of healthcare workers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19255DOI Listing

Outcome domains in Lichen Sclerosus.

Br J Dermatol 2020 May 29. Epub 2020 May 29.

Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.

Lichen Sclerosus (LS) is a chronic inflammatory dermatosis predominantly affecting the genitals. It can affect men, women and children. LS affecting female genitalia typically presents with itchy patches that impact on physical and psychosocial-sexual functioning . Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19253DOI Listing

Absence of Skin of Colour Images in Publications of COVID-19 Skin Manifestations.

Br J Dermatol 2020 May 29. Epub 2020 May 29.

Department of Dermatology, Stanford University School of Medicine, Stanford, CA, United States.

There are now over 1 million confirmed cases of COVID-19 globally with more than 270,000 recorded deaths to date. COVID-19 has been shown to disproportionately impact people of colour both in the United Kingdom and in the United States where blacks make up 13.4% of the population but 30% of COVID-19 cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19258DOI Listing

Does mitochondrial dysfunction of hair follicle epithelial stem cells play a role in the pathobiology of lichen planopilaris?

Br J Dermatol 2020 May 29. Epub 2020 May 29.

Centre for Dermatology Research, University of Manchester, Manchester, UK.

Lichen planopilaris (LPP) is a difficult to treat condition leading to permanent hair loss and scarring. Pathobiologically, LPP shows T- cell mediated interferon-γ driven loss of keratin 15 (K15) positive hair follicle (HF) epithelial stem cells (eHFSCs) due to immune privilege (IP) collapse and pathological epithelial-mesenchymal transition (EMT). This exhausts the eHFSC pool; impacting the HF's capacity to regenerate and cycle and ultimately resulting in HF destruction, fibrosis and scarring. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19259DOI Listing

Are all Buruli ulcers caused by Mycobacterium ulcerans?

Br J Dermatol 2020 May 29. Epub 2020 May 29.

ISEM, UMR226, CNRS, Université de Montpellier, IRD, EPHE, Montpellier, France.

Buruli ulcer (BU) is the third most common mycobacterial disease worldwide and affects mainly poor human populations living in tropical and subtropical areas. In 2018, Africa and Australia reported the most cases (2335 and 358 cases, respectively), followed by French Guiana (FG, 5 cases) and Japan (3 cases). Clinical signs of the disease include painless nodules, plaques and edema followed by the development of skin ulcers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19260DOI Listing

Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.

Br J Dermatol 2020 May 27. Epub 2020 May 27.

Independent Vascular Services Ltd, The Vascular Studies Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, UK.

A range of cutaneous conditions including chilblain-like lesions have been reported in patients with Coronavirus 2019 (COVID-19) due to severe acute respiratory Syndrome coronavirus 2 (SARS-Cov-2). Using clinical data and images, the authors of a recent nationwide Spanish survey identified 5 clinical patterns which were associated with different patient demographics, onset (timing), and prognosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19243DOI Listing

Is targeting circulating T blood cells a therapeutic option for vitiligo?

Authors:
T R Matos

Br J Dermatol 2020 May 26. Epub 2020 May 26.

Department of Dermatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19126DOI Listing

The value of ongoing surveillance on the prevalence of contact sensitization.

Br J Dermatol 2020 May 26. Epub 2020 May 26.

Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19153DOI Listing

Reliability and validity of the Vitiligo Signs of Activity Score.

Authors:
V Eleftheriadou

Br J Dermatol 2020 May 26. Epub 2020 May 26.

University of Nottingham, Centre of Evidence Based Dermatology, King's Meadow Campus, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19164DOI Listing

Meta-analysis results do not reflect the real safety of biologics in psoriasis.

Br J Dermatol 2020 May 23. Epub 2020 May 23.

Université Paris-Est Créteil, UPEC, EpiDermE EA 7379, Créteil, F-94010, France.

Background: In systematic reviews (SR) and meta-analyses (MA) of randomized controlled trials (RCTs) assessing treatments of psoriasis, the proportion of serious adverse events (SAEs) did not differ between treatments and placebo. Including cases of psoriasis worsening as SAEs may explain the lack of difference. This SR and MA aimed to explore this possibility. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19244DOI Listing

Average daily itch versus worst daily itch in chronic itch evaluation.

Br J Dermatol 2020 May 21. Epub 2020 May 21.

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Hospital South Bldg. Suites K-M, 1295 NW 14th St, 33136, Miami, USA.

Chronic itch can be a debilitating medical condition with clinical characteristics and impact akin to chronic pain. Itch severity is subjective and clinicians depend on patient reported numerical ratings scales (NRS); most commonly 24-hour worst itch (WI-NRS) has been validated including large scale studies. WI-NRS does not attempt to take into account itch duration or the variability that is often experienced throughout the day and night by chronic itch patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19228DOI Listing

Dimethyl fumarate modulates the Treg:Th17 cell axis in psoriasis patients.

Br J Dermatol 2020 May 21. Epub 2020 May 21.

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Background: Dimethyl fumarate (DMF) is the active ingredient of Skilarence™ and Tecfidera™ which are used for the treatment of psoriasis and multiple sclerosis, respectively. Various immunomodulatory mechanisms of action have been identified for DMF; however, it is still unclear what effects DMF exerts in vivo in psoriasis patients.

Aim: In this study we examined the effects of DMF, both in vivo and in vitro, on T cells which play a key role in the pathogenesis of psoriasis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19229DOI Listing

Prevalence of hidradenitis suppurativa is one percent of the population of Wales using the Secure Anonymised Information Linkage (SAIL) Databank.

Br J Dermatol 2020 May 20. Epub 2020 May 20.

SAIL Databank, Population Data Science, Data Science Building, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with multiple inflammatory skin lesions ('boils') in flexural locations. Prevalence of HS remains controversial and the study aim was to search the Secure Anonymous Information Linkage (SAIL) Databank to identify diagnosed and undiagnosed HS cases in Wales, UK. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19210DOI Listing

A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.

Br J Dermatol 2020 May 18. Epub 2020 May 18.

Viamet Pharmaceuticals Inc, Durham, North Carolina, USA.

Background: Onychomycosis is a fungal disease that affects the fingernails and toenails and is predominantly caused by dermatophytes. VT-1161 is a novel inhibitor of fungal CYP51 through the inhibition of the lanosterol demethylase, and has demonstrated potent activity against T. rubrum and T. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19224DOI Listing

Altered hydroxymethylation in cutaneous squamous cell carcinoma and keratoacanthoma.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Translational Skin Cancer Research, DKTK Partner Site Essen/Düsseldorf, West German Cancer Center, Dermatology, University Duisburg-Essen, Essen, Germany.

We studied formalin-fixed and paraffin-embedded tissue of patients with cSCC, AK, and KA. We included only lesions that were located on the head and neck region. The study was approved by the ethics review board of the Ruhr-University Bochum (#16-5985). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19219DOI Listing

Pemphigus foliaceus and sand fly bites: assessing the humoral immune response to the salivary proteins maxadilan and LJM11.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Division of Dermatology, Department of Clinical Medicine, Ribeirão, Preto Medical School, University of São Paulo, Ribeirão Preto São Paulo, Brazil.

Roselino et al. (2001) reported the first link between salivary proteins from sand flies and pemphigus foliaceus (PF) pathogenesis on the basis that patients living in a Brazilian region where PF is endemic showed higher titers of IgG antibodies against maxadilan, one of the most immunogenic salivary proteins described in Lutzomyia longipalpis, as compared to healthy controls (HC). For another Brazilian focus, Qian et al. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19221DOI Listing

The effect of a dermato-oncologic training program on the diagnostic skills and quality of referrals for suspicious skin lesions by general practitioners.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Department of Dermatology, Radboud university medical centre, Nijmegen, the Netherlands.

Background: The rising incidence rates of skin cancer (SC) lead to an enormous burden on healthcare systems. General practitioners (GPs) might play an important part in SC care, but research showed poor clinical recognition of SC, leading to a high rate of potentially unnecessary referrals.

Objectives: The aim of this study was to evaluate if a dermato-oncologic training program (DOTP) for GPs improved their diagnostic skills and quality of referrals. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19214DOI Listing

Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis: a critical appraisal.

Authors:
M T Wan J Takeshita

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

The last two decades have seen a rapid growth of targeted biologic therapies for moderate-to-severe plaque psoriasis. While undoubtedly a boon for patients and their treating clinicians alike, the growing number of highly efficacious drug options can make treatment choice challenging. As such, head-to-head randomized controlled trials (RCTs) are necessary to compare the efficacy and safety of therapies to one another. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19216DOI Listing

Detection of genetic tumour predisposition syndromes using electronic health records.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

The restricted tumour repertoire of certain genetic skin tumour syndromes, such as CYLD cutaneous syndrome (CCS), is well recognised. Patients with CCS develop multiple benign cylindromas and spiradenomas, a presentation of skin appendageal tumours recognised to be exclusively associated with CYLD loss. Consequently, pathology coding records, which capture tumour level data, can be interrogated to detect patients who may have undiagnosed CCS based on the presentation of multiple CCS specific tumours over time. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19215DOI Listing

Acral Lentiginous Melanoma: Clinicopathologic Characteristics and Survival Outcomes in the United States National Cancer Database 2004 -2016.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Department of Dermatology, Columbia University Irving Medical Centre, New York, NY, USA.

Acral lentiginous melanoma (ALM) is one of four subtypes of cutaneous melanoma (CM) comprising of 2-3% of all melanomas in the United States. It occurs predominantly on the palms, soles, and nail beds. It is a common subtype found in people with darker skin types. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19211DOI Listing

Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Department of Dermatology. Fundación de Investigación, Biomédica de la Princesa. Hospital Universitario de La Princesa, Madrid, Spain.

Some authors have reported the presence of cutaneous lesions related to new COronaVirus Disease 2019 (CoViD-19) caused by SARS-CoV-2, in up to 20.4% of the cases; however, these lesions are not well characterized either clinically or histopathologically. Recently, it has been highlighted the finding of congested and edematous blood vessels in the alveolar septum along with hyaline thrombi, and also in the heart, liver and kidney of autopsies of 3 patients deceased due to severe infection by SARS-CoV-2. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19222DOI Listing

Interrogation of safety and efficacy of home-use light-based devices.

Authors:
F R Ali F Al-Niaimi

Br J Dermatol 2020 May 14. Epub 2020 May 14.

152 Harley Street, London, W1G 7LH, UK.

We read with interest the short paper describing, and commend the authors on sharing their experience the continued use of phototherapy in COVID-19 affected Italy. Phototherapy is undoubtedly a long-established, relatively safe means of reducing the burden of inflammatory skin disease avoiding large doses of immunosuppression. Home phototherapy devices and services have a long-established use in many countries throughout the world, as described in previous issues of this journal. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19212DOI Listing

Longer duration of lower limb symptoms makes cellulitis diagnosis less likely in secondary care.

Authors:
K Mistry N J Levell

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.

The 2017 Cellulitis Priority Setting Partnership prioritised research into diagnosis and treatment of cellulitis. Cellulitis diagnosis is based on history, examination and inflammatory markers. No validated diagnostic criteria or tools exist and up to 68% with suspected lower limb cellulitis (LLC) may not have the condition leading to unnecessary hospital admission and antibiotic treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19213DOI Listing

Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.

Ifosfamide + etoposide (I+E) have been used to treat lymphomas, combined with platinum-based agents in Hodgkin disease or non-Hodgkin lymphomas including peripheral T-cell lymphomas. Monoclonal antibodies have induced long-term remissions in CTCL but are usually poorly effective in transformed disease. Allogeneic hematopoietic stem cell transplantation (alloHSCT) holds a potential for cure but relies on the existence of a pre-transplant CR which may require the use of chemotherapeutic regimens. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19220DOI Listing

Discovery of heterozygous KRT10 alterations in MAUIE patients underlines the importance of regular skin cancer screening in ichthyosis with confetti-patients.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Mercy Hospitals of Bakersfield, Bakersfield, California, USA.

Ichthyosis with confetti (IWC) (OMIM#609165), also known as congenital reticular ichthyosiform erythroderma (CRIE), is an autosomal dominant genodermatosis with erythroderma on the entire body surface. Unique to IWC is the development of 100s and 1000s of pale spots resembling healthy skin. Almost 20% of the patients develop non-melanoma skin cancer (NMSC) in early adulthood for unknown reasons. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19218DOI Listing

Fee-for-service and structural forces may drive racial disparities in US dermatology.

Br J Dermatol 2020 May 14. Epub 2020 May 14.

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Despite controversy, fee-for-service (FFS) remains the predominant insurance model in the United States. Under FFS, physicians are incentivized to perform services based on negotiated rates by insurance companies. These agreed upon rates for reimbursements may indirectly drive overutilization, specifically of procedures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19217DOI Listing

Sudden appearance of pruritic eruption with comet sign due to Pyemotes sp.

Br J Dermatol 2020 May 12. Epub 2020 May 12.

Department of Dermatology, University of Tours, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19140DOI Listing

Erythroderma in a newborn infant suggesting Omenn syndrome.

Br J Dermatol 2020 May 12. Epub 2020 May 12.

Department of Dermatology and Dermatological Surgery, Medical University of South Carolina, 135 Rutledge Ave, Charleston, 29425, SC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19138DOI Listing

A new biomarker for psoriatic arthritis?

Br J Dermatol 2020 May 12. Epub 2020 May 12.

Conway Institute for Biomolecular Research, School of Medicine, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19141DOI Listing

Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.

Br J Dermatol 2020 May 10. Epub 2020 May 10.

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.18966DOI Listing

Epidermolysis bullosa: a 2020 perspective.

Authors:
E Pope

Br J Dermatol 2020 May 10. Epub 2020 May 10.

The Hospital for Sick Kids, 555 University Avenue, Toronto, ON, Canada, M5G 1X8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19125DOI Listing

Topical condyloma treatment: comparative evidence for a common problem.

Authors:
P Doiron

Br J Dermatol 2020 May 10. Epub 2020 May 10.

Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, ON, M5S 1B2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19044DOI Listing

Congenital multiple clustered dermatofibroma on the abdomen.

Br J Dermatol 2020 May 10. Epub 2020 May 10.

Department of Dermatology, Ruprecht-Karls-University Medical Center, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19139DOI Listing

Stress and melanoma. Myth or reality?

Br J Dermatol 2020 May 10. Epub 2020 May 10.

First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Faculty of Medicine, 'A. Sygros' Hospital for Cutaneous & Venereal Diseases, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19035DOI Listing

Sensitivity to change and Correlation between Autoimmune Bullous Disease Quality of Life questionnaires ABQOL and TABQOL, and objective severity scores.

Br J Dermatol 2020 May 6. Epub 2020 May 6.

Department of Dermatology, Rouen University Hospital, INSERM U905, Centre de référence des maladies bulleuses autoimmunes, Normandie University, Rouen, France.

The Autoimmune-Bullous-Disease-Quality-of-Life (ABQOL) score is moderately correlated to pemphigus objective-severity-scores (OSS) (with Pemphigus-Disease-Area-Index (PDAI): R =0.42) but is sensitive to change. The Treatment-of-Autoimmune-Bullous Disease-Quality-of-Life (TABQOL) score is weakly correlated to pemphigus OSS (PDAI: R=0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.19173DOI Listing